China SXT Pharmaceuticals Announces $9M Registered Direct Offering
China SXT Pharmaceuticals (NASDAQ:SXTC) announced a registered direct offering of 4.5 million units at $2.00 per unit, expected to raise approximately $9 million in gross proceeds. The transaction is set to close on or around July 24 with Univest Securities as the sole placement agent.
Topics: capital raise registered direct offering stock issuance